
Human Lactadherin 97-105, GLQHWVPEL
Description
About Human Lactadherin 97-105, GLQHWVPEL
The Human Lactadherin Peptide (IEDB: 772729) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Lactadherin Peptide, H-GLQHWVPEL-OH (Uniprot: Q08431 aa: 97-105) from JPT is produced under strict quality control and quality management.
Human Lactadherin 97-105, GLQHWVPEL - Specifications
- Peptide sequence: H-GLQHWVPEL-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Breast cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Lactadherin 97-105, GLQHWVPEL
References:
Read References with JPT’s Antigen Peptides
Human Lactadherin 97-105, GLQHWVPEL has been described in:
The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients., Cancer Res, 2006 (PMID: 16912206)
Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade., Front Immunol, 2022 (PMID: 35874702)
Documentation
Documentation for Human Lactadherin 97-105, GLQHWVPEL
Properties
Properties of Human Lactadherin 97-105, GLQHWVPEL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Breast cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Lactadherin 97-105, GLQHWVPEL
Information | Values |
---|---|
Sequence: | H-GLQHWVPEL-OH |
Specifications: | 9mer peptide as TFA salt |